Cardinal Management In Sync: Parrish To Head Distribution After Syncor Deal
Executive Summary
Cardinal's drug distribution business will be led by Mark Parrish after a management reshuffling triggered by the acquisition of Syncor
You may also be interested in...
Cardinal Plans Generic Cardiolite, Other Moves To Expand Generic Presence
Cardinal Health expects to market its own generic version of Bristol-Myers Squibb's cardiac imaging agent Cardiolite (technetium Tc99m sestamibi) as part of a plan to expand its role in the generic sector
Cardinal Plans Generic Cardiolite, Other Moves To Expand Generic Presence
Cardinal Health expects to market its own generic version of Bristol-Myers Squibb's cardiac imaging agent Cardiolite (technetium Tc99m sestamibi) as part of a plan to expand its role in the generic sector
Cardinal Manufacturing Helped By FDA Compliance Crackdown, Firm Says
FDA's crackdown on pharmaceutical GMP compliance is expanding the outsourcing opportunities for contract manufacturers, Cardinal Health Life Sciences Products & Services President George Fotiades told the J.P. Morgan H&Q conference in San Francisco Jan. 7